Navigation Links
ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
Date:5/20/2008

BUENOS AIRES, Argentina, May 21 /PRNewswire-FirstCall/ -- Today at the World Congress of Cardiology (WCC), the press conference entitled "New Perspectives in Atrial Fibrillation Management" chaired by John Camm, Professor of Clinical Cardiology, St George's University of London, highlighted the importance of the newly announced ATHENA clinical trial results, as the way forward in the future management of Atrial fibrillation, the most common form of cardiac arrhythmia.

To view the Multimedia News Release, please click: http://www.prnewswire.com/mnr/sanofiaventis/33333/

"ATHENA is truly a landmark trial, that marks a paradigm change for the management of atrial fibrillation," said Prof Christopher Cannon, a Senior Investigator in the TIMI Study Group at Brigham and Women's Hospital, Harvard Medical School, who was not involved in the study. "Atrial fibrillation is a very common disease, and our prior treatment options have been focused only on symptom relief and a hope to not do harm, which has been the problem with prior antiarrhythmic drugs. Now, with a highly significant reduction in cardiovascular hospitalisation or death, as well as a 45% reduction in arrhythmic death or 30% cardiovascular death, dronedarone may become a first line treatment of atrial fibrillation."

The ATHENA study results were presented by Prof Stefan Hohnloser last week (15th May 08) at the Heart Rhythm Society's 29th Annual Scientific Sessions in San Francisco, USA. The study results show that dronedarone significantly decreased the risk of cardiovascular hospitalisations or death from any cause by 24% (p=0.00000002), meeting the study's primary endpoint. Results of the primary endpoint were consistent across all the pre-specified clinically relevant subgroups.

The most frequently reported adverse events of Multaq(R) vs. placebo in the ATHENA trial were gastro-intestinal effects (
'/>"/>

SOURCE Sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
2. Multi-Center Patient Registry Supports Safety and Clinical Utility of Boston Scientifics SpyGlass(R) Direct Visualization System
3. Tioga Pharmaceuticals Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome
4. Ardea Biosciences Presents Preclinical Data on RDEA119 Demonstrating Favorable Anti-Inflammatory Profile for Potential Use in Ulcerative Colitis
5. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients
8. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
9. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
10. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
11. Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... --  Cepheid (Nasdaq: CPHD ) today announced that ... quarter ended June 30, 2015 on Thursday, July 23, ... The Company will host a management presentation at 2 ... discuss the results.  To access the live webcast, please ... 15 minutes before the scheduled start time to download ...
(Date:7/6/2015)... 6, 2015 /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: ... retail drugstore chain in China ... announced that its board of directors has received a ... Simin Zhang , chairman of the board of ... Ltd., an investment vehicle wholly owned by Mr. Zhang(" ...
(Date:7/3/2015)... , July 4, 2015 ... cible les épidémies que sont l,hypertension, le diabète ... du Sud-Est, par l,intermédiaire de plateformes éducatives gratuites ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) ... charge le diabète en ligne , Prendre ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3
... AVENTURA, Fla., Aug. 15, 2011 Double Eagle ... has retained National Securities Corporation as the ... round of capitalization, as well as possible acquisition and ... company of Fuse Science, Inc. ( www.fusescience.com ), the ...
... MINNETONKA, Minn., Aug. 15, 2011 Uroplasty, Inc. (Nasdaq: ... develops, manufactures and markets innovative proprietary products to treat ... clinical studies using Uroplasty,s Urgent® PC Neuromodulation System are ... meeting, August 29-September 2, 2011 in Glasgow, Scotland.   ...
Cached Medicine Technology:Double Eagle Holdings Chooses National Securities Corporation as Exclusive Investment Banker 2Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society 2Urgent® PC Clinical Studies Results Scheduled for Presentation at International Continence Society 3
(Date:7/6/2015)... ... July 06, 2015 , ... Hundreds of ... aesthetic reasons, which is why liposuction regularly ranks among the top five most ... reduction has become more than a way to slim down a silhouette for ...
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... ... disease prevention in southern California, has partnered with Woodbridge Walk-In Urgent Care to ... cancer, stroke and other serious medical conditions. Screenings are affordable and accurate and ...
(Date:7/6/2015)... Bay, Florida (PRWEB) , ... July 06, 2015 , ... ... facility on Monday, July 6. The newly constructed urgent care center will serve residents ... services. , In addition to being MD Now’s 22nd South Florida location, the new ...
(Date:7/6/2015)... MD (PRWEB) , ... July 06, 2015 , ... Dr. ... and Washington, DC, area patients. Kybella is a non-surgical method to dissolve ... use of reducing moderate to severe fat deposits under the chin, commonly known as ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Path of Least ... the economic transformation associated with the U.S. economy over the past 40 years. The ... its use. In many ways, the book is a time capsule that chronicles the ...
Breaking Medicine News(10 mins):Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2
... largest employers will expand and create more than 200 ... investment by the commonwealth., Uniontown Hospital will receive ... Authority, on behalf of the Fayette Regional,Health System, which ... to jump start the construction of a new,inpatient tower ...
... Honors for Corporate Support in Fighting Childhood Cancer ... This year you can wear your,Halloween costume twice ... children with cancer who need help in paying medical ... turn out in their,favorite super hero costumes at this ...
... The American Heart,Association and its Pharmaceutical Roundtable ... Research Centers initiative. The project,will provide a network ... results, or outcomes, of healthcare for people with ... The initiative is supported in part by a ...
... CEO of America,s Health Insurance Plans (AHIP), today ... "We congratulate President-elect Barack Obama for his historic ... care reform, and we look forward to,working with ... develop,workable solutions to the health care challenges facing ...
... The American,Nurses Association (ANA) congratulates President-Elect Barack Obama ... with the new administration,and new lawmakers to affect ... President-Elect Barack Obama has been a consistent ... and as a U.S. Senator,Barack Obama has shown ...
... reform in 2009, WASHINGTON, Nov. 5 The ... "The American Medical Association congratulates President-elect Barack,Obama on ... States. He has,proposed a serious framework for health system ... his campaign., "The AMA shares President-elect Obama,s focus ...
Cached Medicine News:Health News:State to Invest $8.4 Million in Uniontown Hospital's Expansion 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 3Health News:Four Medical Centers Awarded Funds to Improve Outcomes Research for Heart Disease and Stroke 2Health News:AMA Congratulates President-Elect Obama 2
Latex agglutination test for the qualitative and semiquantitative determination of rheumatoid factor in serum....
Test for determination of rheumatoid factor....
... Equipped with the SYNCHRON CX4 ... most advanced and automated technologies, your ... process dramatically. The SYNCHRON CX4 PRO ... other specialty tests, such as thyroid, ...
... Delta Specialty / Drug Clinical System ... can consolidate Drugs of Abuse, TDM's ... thyroid, HbA1c and lipids in one ... a level of automation and flexibility ...
Medicine Products: